Nancy Leaming, Director at BIOGEN IDEC INC. (BIIB), sold 3,000 shares at $116.00 ($348K) on 2012-01-06, disclosed to the SEC on 2012-01-09.
Scheduled sale ($348k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| HOLX | SELL | 2017-01-05 | $700K | — | Filing → |
| HOLX | SELL | 2016-07-25 | $303K | — | Filing → |
| HOLX | SELL | 2016-07-12 | $224K | — | Filing → |